Insiders / Fennell George / Activity
Activity — Fennell George
24 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +204 +2.03% | 10,277 0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +139 +1.40% | 10,073 0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +56 +0.57% | 9,934 0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $0 | +55 +0.56% | 9,878 0.01% of shares | low |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $26.0K | -40 -0.41% | 9,823 0.01% of shares | low |
| Feb 9, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $100.1K | +1K +17.68% | 9,823 0.01% of shares | low |
| Feb 14, 2026 | Other | IDXX Idexx Laboratories Inc /De Common Stock | $125.2K | -199 -1.94% | 10,078 0.01% of shares | low |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $255.7K | -397 -1.98% | 19,641 0.02% of shares | medium |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $626.7K | -966 -7.08% | 12,672 0.02% of shares | medium |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $686.0K | -1K -7.21% | 13,638 0.02% of shares | medium |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $726.6K | -1K -5.34% | 20,038 0.03% of shares | medium |
| Feb 10, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Common Stock | $769.8K | +11K +115.49% | 21,168 0.03% of shares | low |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.39M | -2K -11.00% | 17,480 0.02% of shares | medium |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.80M | -3K -15.92% | 14,698 0.02% of shares | medium |
| Feb 10, 2026 | Sell | IDXX Idexx Laboratories Inc /De Common Stock | $1.82M | -3K -22.17% | 9,863 0.01% of shares | medium |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -204 -25.00% | 612 <0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -139 -33.33% | 278 <0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -56 -50.00% | 56 <0.01% of shares | low |
| Feb 14, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | -55 -100.00% | 0 0.00% of shares | low |
| Feb 12, 2026 | Grant | IDXX Idexx Laboratories Inc /De Restricted Stock Unit | — | +810 | 810 <0.01% of shares | low |
| Feb 12, 2026 | Grant | IDXX Idexx Laboratories Inc /De Incentive Stock Option (right-to-buy) | — | +162 | 162 <0.01% of shares | low |
| Feb 12, 2026 | Grant | IDXX Idexx Laboratories Inc /De Non-Qualified Stock Option (right-to-buy) | — | +3K | 3,384 <0.01% of shares | low |
| Feb 10, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Non-Qualified Stock Option (right-to-buy) | — | -11K -100.00% | 0 0.00% of shares | low |
| Feb 9, 2026 | Exercise | IDXX Idexx Laboratories Inc /De Incentive Stock Option (right-to-buy) | — | -1K -100.00% | 0 0.00% of shares | low |